Keywords: نئوپلاسم پروستات; Laparoscopy; Prostate; Prostatectomy; Prostatic neoplasms; Risk;
مقالات ISI نئوپلاسم پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نئوپلاسم پروستات; prostatic neoplasms; urethra; urinary sphincter; artificial; radiotherapy; treatment outcome; AUS; artificial urinary sphincter; PCa; prostate cancer;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; biomarkers; tumor; kallikreins; African Americans; neoplasm grading; AA; African American; DRE; digital rectal examination; GG; Grade Group; PSA; prostate specific antigen;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Pathology; Biopsy; Large-core Needle;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; neoplasm recurrence; local; prostatectomy; prognosis; ACM; all cause mortality; BCR; biochemical recurrence; CRPC; castration resistant prostate cancer; ePSADT; early PSADT; PCSM; prostate cancer specific mo
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; United States; Epidemiology; Neoplasm metastasis;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; neoplasm recurrence; local; prostate specific antigen; magnetic resonance imaging; biomarkers; tumor; 3D; 3-dimensional; 3TmpMRI; 3 Tesla prostate mpMRI; ADC; apparent diffusion coefficient; BCR; biochemical recurrence; mpMRI; multipa
Keywords: نئوپلاسم پروستات; prostatic neoplasms; stress; psychological; sexual dysfunction; physiological; urination disorders; quality of life; AJCC; American Joint Committee on Cancer; PCa; prostate cancer; PSA; prostate specific antigen;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; high-intensity focused ultrasound ablation; registries; patient outcome assessment; biomedical technology; CRN; coordinated registry network; EPIC-26; Expanded Prostate Cancer Index Composite-26; FDA; Food and Drug Administration; HIF
Keywords: نئوپلاسم پروستات; prostatic neoplasms; magnetic resonance imaging; ultrasonography; early diagnosis; biopsy; AIM; actionable intelligence metric; AS; active surveillance; BN; biopsy naïve; GG; Gleason Grade Group; mpMRI; multiparametric MRI; MRI; magnetic resonance imagin
Keywords: نئوپلاسم پروستات; prostatic neoplasms; watchful waiting; prostatectomy; risk; safety; AS; active surveillance; JHU; Johns Hopkins University; MRI; magnetic resonance imaging; PSA; prostate specific antigen; PSAD; PSA density; RP; radical prostatectomy;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; watchful waiting; genomics; risk factors; pathology; surgical; GPS; Genomic Prostate Scoreâ¢; GrdGrp; Gleason grade group; LFP; likelihood of favorable pathology; LR; low risk; NCCN®; National Comprehensive Cancer Network®; PSA; pr
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Health care disparities; Health care quality;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostatectomy; robotic surgical procedures; depression; sexual dysfunctions; physiological; BDI; Beck Depression Inventory; ED; erectile dysfunction; EF; erectile function; IIEF; International Index of Erectile Function; MVA; multivar
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; socioeconomic factors; mortality; NH; nonHispanic; NHIS; National Health Interview Survey; PM; predicted marginal; PSA; prostate specific antigen; RR; rate ratio; SEER; Surveillance, Epidemio
Keywords: نئوپلاسم پروستات; Cancer trends; Disease progression; Epidemiology; Neoplasm metastases; Prostate-specific antigen; Prostate cancer; Prostatic neoplasms; Racial disparities;
Keywords: نئوپلاسم پروستات; AMS; American medical systems; bPFS; biochemical progression-free survival; CTCAE; common terminology criteria for adverse events; DMFS; distant metastasis-free survival; DSS; disease specific survival; GI; gastrointestinal; GU; genitourinary; Gy; gray;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostatectomy; urinary incontinence; treatment outcome; quality of life; LUTS; lower urinary tract symptoms; ORRP; open radical retropubic prostatectomy; PSA; prostate specific antigen; RP; radical prostatectomy; RT; radiotherapy; UC;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; magnetic resonance imaging; ultrasonography; biopsy; diagnostic imaging; CS-PCA; clinically significant PCA; MRI; magnetic resonance imaging; PCA; prostate cancer; PI-RADS⢠v2; Prostate Imaging Reporting and Data System, version 2;
Keywords: نئوپلاسم پروستات; Quality indicators; Healthcare; Radiotherapy; Prostatic neoplasms; Quality of health care;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Lymphatic metastasis; Prostatectomy; Prognosis; Adjuvant radiotherapy; Antineoplastic agents; Hormonal; Mortality;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; image-guided biopsy; magnetic resonance imaging; ultrasonography; diagnostic imaging; AS; anterior stroma; FUS-GB; MRI/ultrasound fusion guided biopsy; GS; Gleason score; mp-MRI; multiparametric MRI; MRI; magnetic resonance imaging; P
Keywords: نئوپلاسم پروستات; prostatic neoplasms; biopsy; inflammation; prostate-specific antigen; risk factors; PCa; prostate cancer; PNB; prostate needle biopsy; PSA; prostate specific antigen;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; neoplasm grading; prostatectomy; watchful waiting; clinical decision-making; AS; active surveillance; ASIST; Active Surveillance Magnetic Resonance Imaging Study; BCR; biochemical recurrence; EPE; extraprostatic extension; GrdGrp; Gra
Keywords: نئوپلاسم پروستات; prostatic neoplasms; watchful waiting; neoplasm grading; prostatectomy; risk factors; AS; active surveillance; BCR; biochemical recurrence-free; FIR; favorable intermediate risk; GG; Grade Group; GS; Gleason score; LNI; lymph node involvement; LR; low ris
Keywords: نئوپلاسم پروستات; prostatic neoplasms; neoplasm metastasis; SEER Program; practice guidelines as topic; mortality; PCSM; prostate cancer specific mortality; PLNM; pelvic lymph node metastases; SEER; Surveillance, Epidemiology and End Results;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; biomarkers; tumor; neoplastic cells; circulating; bone marrow; neoplasm metastasis; 4P; PSA, PAP, PSCA and PSMA cocktail; AR; androgen receptor; BM; bone marrow; CK; pan-cytokeratin; CTC; circulating tumor cell; DTC; disseminated tumo
Keywords: نئوپلاسم پروستات; prostatic neoplasms; watchful waiting; phototherapy; risk; neoplasm grading; GG; Gleason Grade Group; MCCL; maximum cancer core length; MRI; magnetic resonance imaging; PCa; prostate cancer; PGA; partial gland ablation; RP; radical prostatectomy; RT; radi
Keywords: نئوپلاسم پروستات; prostatic neoplasms; United States Food and Drug Administration; patient preference; clinical decision making; equipment and supplies; AS; active surveillance; BOO; bladder outlet obstruction; FDA; Food and Drug Administration; HIFU; high intensity focuse
Keywords: نئوپلاسم پروستات; prostatic neoplasms; robotic surgical procedures; anastomosis; surgical; education; task performance and analysis; APM; automated performance metric; CTA; cognitive task analysis; CVI; content validity index; NAPM; nonAPM; RRP; robotic assisted radical pr
Keywords: نئوپلاسم پروستات; Active surveillance; Biopsy; Cancer location; Cumulative cancer locations; Diagnosis; Discontinuation; Gleason upgrade; Prostatic neoplasms; Pathology; Survival;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; testosterone; hypogonadism; prostate-specific antigen; risk factors; AR; androgen receptor; BMI; body mass index; CV; coefficient of variation; MMD; median of maximum declines in 24-month screening window; MMDRM; ratio of maximum decl
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Neoplasm recurrence; Biochemical tumour markers; Radiotherapy; Salvage therapy;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Magnetic resonance imaging (MRI); Image-guided biopsy; Prostatic biopsy;
Keywords: نئوپلاسم پروستات; androgen antagonists; dementia; prostatic neoplasms; Alzheimer disease; cognition; ADT; androgen deprivation therapy; ICCTF; International Cognition and Cancer Task Force;
Keywords: نئوپلاسم پروستات; prostate-specific antigen; prostatic neoplasms; transplantation; graft survival; cPSA; complexed PSA; ESLD; end stage liver disease; ESRD; end stage renal disease; fPSA; free PSA; HD; hemodialysis; MMF; mycophenolate mofetil; PSA; prostate specific antige
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; global burden of disease; incidence; mortality; ASDR; age standardized death rate; ASIR; age standardized incidence rate; DALY; disability adjusted life-year; GBD; Global Burden of Disease; PCa; prostate can
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Mortality; Radiotherapy; Adverse effects; Prostatectomy; Comparative effectiveness research; Brachytherapy; Quality of life;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Prostate Cancer; Treatment; Mortality; Observational; Systematic Review;
Keywords: نئوپلاسم پروستات; Prostatic neoplasms; Prostate-specific antigen; Mass screening; Randomised controlled trial; Costs and cost analysis;
Keywords: نئوپلاسم پروستات; urology; patient-centered care; prostatic neoplasms; Medicare Access and CHIP Reauthorization Act of 2015; APC; advanced prostate cancer; APM; alternative payment model; CCM; chronic care management; CMS; Centers for Medicare and Medicaid Services; CPIA;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; mass screening; mortality; failure to rescue; health care; early detection of cancer; DRE; digital rectal examination; ERSPC; European Randomized study of Screening for Prostate Cancer; PSA; prostate specific antigen; TRUS; transrecta
Keywords: نئوپلاسم پروستات; testis; prostatic neoplasms; vasectomy; vasovasostomy; risk factors;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostatectomy; neoplasm grading; neoplasm invasiveness; pathology; surgical; GS; Gleason score; GS347; GS 3 + 4 = 7; ISUP; International Society of Urological Pathology; RP; radical prostatectomy;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; prostatectomy; neoplasm recurrence; local; early detection of cancer; BCR; biochemical recurrence; CSS; cancer specific survival; MFS; metastasis-free survival; PSA; prostate specific antigen; RP; radical pr
Keywords: نئوپلاسم پروستات; prostatic neoplasms; guidelines as topic; prostate-specific antigen; advisory committees; AUA; American Urological Association; ERSPC; European Randomized Study of Screening for Prostate Cancer; PCa; prostate cancer; PLCO; Prostate, Lung, Colorectal and O
Keywords: نئوپلاسم پروستات; prostatic neoplasms; decision support techniques; medical informatics; surveys and questionnaires; planning techniques; DC; decisional conflict; DCS; DC scale; LPC; localized prostate cancer; LS; least squares; P3P; Personal Patient Profile-Prostate; UC;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; sexual and gender minorities; erectile dysfunction; urinary incontinence; sexual behavior; GBM; gay and bisexual men; U.S.; United States;
Keywords: نئوپلاسم پروستات; prostatic neoplasms; prostate-specific antigen; brachytherapy; androgen antagonists; disease-free survival; ADT; androgen deprivation therapy; bDFS; biochemical disease-free survival; BF; biochemical failure; EBRT; external beam radiotherapy; LDR-BT; low
Keywords: نئوپلاسم پروستات; prostatic neoplasms; magnetic resonance imaging; neoplasm staging; AS; active surveillance; DWI; diffusion weighted imaging; EPE; extraprostatic extension; LN; lymph node; MR; magnetic resonance; PCa; prostate cancer; PI-RADS; Prostate Imaging Reporting a